1 / 26

Moms on Meds

Moms on Meds. Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D. Prescription Painkiller Overdoses. July 2013.

Download Presentation

Moms on Meds

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.

  2. Prescription Painkiller Overdoses. July 2013 • Approximately 18 women die every day of a prescription painkiller overdose in the US. More than 6,600 deaths in 2010 • Deaths from prescription painkiller overdoses among women have increased more than 400% since 1999, compared to 265% increase among men • Prescription painkillers are involved in 1 in 10 suicides among women. • For every woman who dies of a prescription painkiller overdose, 30 go to the ER for painkiller misuse or abuse • “Prescription Painkiller Overdoses”. (2013). Retrieved on August 4, 2013, from http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/

  3. Prescription painkiller overdose deaths are a growing problem among women

  4. 2010 National Survey on Drug Use and Health 4.4% of pregnant women reported use of an illicit substance within the past 30 days Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41. HHS Publication No. (SMA) 11-4658. Rockville (MD) SAHMSA: 2011

  5. Deliveries at LeConte Medical Center

  6. Maternal Complications of Substance Abuse • Many barriers exist for pregnant substance abusers • Lifestyle issues may result in pregnant women engaging in high risk behavior • Prostitution • Sharing of IV needles • Intimate Partner Violence • Theft and other criminal activities

  7. Maternal Complications of Substance Abuse Confounding variables of substance abuse • Socioeconomic status • Ethnicity • Access to prenatal care • Poly-substance abuse

  8. Substances Most Commonly Abused During Pregnancy • Tobacco • Alcohol • Marijuana • Opiates • Cocaine • Benzodiazepines • Amphetamines • Hallucinogens

  9. Opioid Addiction • Oxycodone • Hydrocodone • Methadone • Roxicodone • Heroin • Fentanyl • Meperidine • Hydromorphone • Propoxyphene

  10. Opioid use in Pregnancy: Maternal Complications • Altered Mental Status • Somnolence • Respiratory Depression • Death • IV Use may result in • Hepatitis B & C • HIV • Skin infections • Endocarditis • Sepsis

  11. Opioid Effects on Pregnancy Antenatal Complications Neonatal Effects Neonatal Abstinence Syndrome (NAS) • Preterm Delivery • Growth Restriction • Low Birth Weight • Placental Abruption • Fetal Death

  12. Neonatal Abstinence Syndrome (NAS) • Constellation of withdrawal symptoms • Central Nervous System • Inconsolability, high-pitched crying, skin excoriation, hyperactive reflexes, tremors, seizures • Gastrointestinal System • Poor feeding, excessive sucking, feeding intolerance, loose or watery stools • Autonomic/metabolic • Sweating, nasal stuffiness, sneezing, fever, tachypnea, mottling

  13. Treatment options • Holistic Multidisciplinary Approach to treatment of Neonatal Abstinence Syndrome • Non-pharmacological • Cuddler • Environmental • Diet • Pharmacological • Narcotics • Non-narcotics

  14. Pharmacological Treatment • Approximately 67% of babies • Are weaned from opioid in about 20 days • Do not require adjuvant treatment • Stay in the NICU approximately 24 days • Approximately 33% of babies • Require weaning time of 60 days (range up to 155 days) • Require adjuvant treatment with up to two additional medications • Stay in the NICU for about 68 days (some up to 155 days)

  15. Mother’s TennCare status at time of delivery for NAS children

  16. TennCare cost associated with treatment of NAS infants

  17. Treatment of Substance Abuse During Pregnancy

  18. Screening • Universal Screening of all women before and during pregnancy • Identify women currently using illicit substances & women at risk • Toxicology testing: Urine Drug Screens

  19. Intervention • Multidisciplinary approach needed to address Physical, Psychological and social issues • Obstetrical and Neonatal Care • Addiction Medicine Specialist • Mental Health Services • Social Services

  20. Treatment of Opioid Addiction in Pregnancy • For Opioid addicted Pregnant patients: • Detoxification • Relapse rates are high and dangerous • Opioid Replacement Therapy • Methadone versus Buprenorphine • Alcohol and Drug Counseling • Treatment of Co-existing Mental Health Disorders

  21. Treatment of Opioid Addiction in Pregnancy • “Comprehensive care provided at one location is cost effective and produces better outcomes for both mother and child.” Early Start Program at Kaiser Permanente, California Patients who were screened, assessed and treated had lower rates of preterm delivery, low birth weight, and neonatal-assisted ventilation Wong, S. (2011, April). Substance Use in Pregnancy. Journal of Obstetrics and Gynaecology Canada. 33(4): 367-384

  22. American College of Obstetrics & Gynecology Committee Opinion in 2004 wrote that “using a protocol for universal screening, brief intervention, and referral to treatment…results in a mean net savings of $4644 in medical expenses per mother/ infant pair.”

  23. Treatment Cost Considerations Annual treatment cost for a person with drug addiction Reference: Position Paper on Drug Policy published by the Physician Leadership on National Drug Policy January, 2000. Data source: Center for Substance Abuse Treatment, Federal Bureau of Prisons. 1997 National Treatment Improvement Evaluation Study

  24. Pregnancy is an ideal time to provide intervention to women with substance abuse problems, as motivation to modify harmful behavior is increased.

More Related